Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
48.65
-3.72 (-7.10%)
Mar 31, 2025, 1:17 PM EDT - Market open
Disc Medicine Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$83.80
Upside
+72.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $99 → $132 | Buy | Maintains | $99 → $132 | +171.35% | Mar 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $85 | Buy | Initiates | $85 | +74.74% | Mar 7, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $73 → $75 | Buy | Maintains | $73 → $75 | +54.18% | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $90 → $94 | Strong Buy | Maintains | $90 → $94 | +93.24% | Jan 24, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $70 → $73 | Buy | Maintains | $70 → $73 | +50.07% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $118 | Strong Buy | Reiterates | $118 | +142.57% | Jan 21, 2025 |
| Stifel | Stifel | Strong Buy Maintains $79 → $90 | Strong Buy | Maintains | $79 → $90 | +85.01% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $118 | Strong Buy | Reiterates | $118 | +142.57% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $118 | Strong Buy | Maintains | $70 → $118 | +142.57% | Nov 13, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $62 → $70 | Buy | Maintains | $62 → $70 | +43.90% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +43.90% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +43.90% | Oct 28, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $89 | Strong Buy | Initiates | $89 | +82.96% | Oct 23, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $62 | Buy | Initiates | $62 | +27.45% | Oct 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $85 | Buy | Reiterates | $85 | +74.74% | Oct 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $85 | Buy | Reiterates | $85 | +74.74% | Sep 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.